Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
Research uncovers new driver of immunotherapy resistance in pancreatic cancer
ReCatalyst closes oversubscribed seed financing round